BLOODPAC

🎯 The Advancing Precision Medicine Annual Conference is happening on November 1-2, 2024 in Philadelphia, PA, and we’re thrilled to be part of it! 🗓️ On November 1st from 10:50-11:50 AM EST, our Executive Director, Lauren C. Leiman, will join Dr. Phillip G. Febbo, MD (Co-chair of LBX Accessibility) and Lee-Anne Zinetti (FT3) in a panel moderated by Nicole St Jean (PCC). ➡️ The topic: "Who Needs Liquid Biopsy? Opportunities to Increase Access and Improve Outcomes." Don’t miss this insightful discussion about liquid biopsy’s impact on cancer care. ❗ Register for FREE using the code BLOODPAC https://lnkd.in/g7Dz8yFb #PrecisionMedicine #LiquidBiopsy #BLOODPAC #CancerInnovation #AdvancingHealthcare

We had a wonderful time hosting BLOODPAC's Q3 in-person meeting last month! This event brought together industry leaders advancing the #LiquidBiopsy field for two days of dynamic discussion, meaningful collaboration, and some good fun! Huge thank you to all those who helped organize and lead a great event (Lauren C. Leiman, Dorys L., Cheyenne Jankiewicz, Matthew M., Dan Norton, MBA, Olga Alexeeva, Alvaro Rodriguez, Tara Andersen, Judith de Perio (Cooper), James Fink, Polo Alvarado, Francisco Escalante, Alan Duong, and many more). Check out the highlights below…

There’s not long to go until we head to Boston for the Liquid Biopsy Surveillance Summit (November 21-22)! As the leading East Coast forum with a focus on advancing the monitoring of patients through cutting-edge minimal residual disease (MRD) detection, our pioneering speaker faculty will take to the stage to explore the future of MRD-driven surveillance and the transformative impact it has on personalized cancer care. Here’s just a quick snapshot of our expert speakers: Janet J., Amgen Gabriele Allegri, Johnson & Johnson Judy Keen, Foundation for the National Institutes of Health Jean-Francois Martini, Pfizer Kris F. Sachsenmeier, Compass Therapeutics Inc. Lauren C. Leiman, BLOODPAC Access the event guide: https://ter.li/wk73kc

Almost a month since our Q3 meeting! In this clip Dan Norton, MBA from Personalis, Inc. and co-chair of our MRD Clinical Validation Working Group shares his takeaways on BLOODPAC’s Q3 meeting. Dan's key insight: in-person collaboration accelerates progress and offers a unique opportunity to witness the impressive work across other groups. It’s a great reminder of how teamwork drives innovation. 🙌 A big thank you to Dan and the rest of the team at Personalis, Inc. for hosting and facilitating collaboration among our working groups! #LiquidBiopsy #MRDclinicalvalidation

Are you attending the Advancing Precision Medicine conference? Join BLOODPAC on November 1st from 10:50-11:50 AM EST for a dynamic panel discussion featuring our Executive Director, Lauren C. Leiman, alongside Dr. Phillip G. Febbo, MD (BLOODPAC member & Co-chair of LBX Accessibility) and Lee-Anne Zinetti (FT3, Board member), moderated by Nicole St Jean (PCC, Chair). ➡️ The topic: "Who Needs Liquid Biopsy? Opportunities to Increase Access and Improve Outcomes." We can't wait to dive into this important conversation on liquid biopsy and its potential to transform cancer care. Hope to see you there! Find out more about the conference and register here: https://lnkd.in/g7Dz8yFb #PrecisionMedicine #LiquidBiopsy #CancerResearch #BLOODPAC

Meeting face-to-face at Personalis, Inc. for our Q3 meeting made all the difference! Day 2 was filled with dynamic discussions as our teams shared their latest advancements. It’s amazing how much we can accomplish when we come together. Listen to Adam Corner from Bio-Rad Laboratories share his BLOODPAC Q3 meeting takeaways.

Our Q3 meeting at Personalis, Inc. highlighted the power of in-person collaboration, driving our working groups closer to achieving key milestones. Day 1 was full of focused teamwork, productive discussions, and clear decision-making, all paving the way toward our goals. Hear some takeaways from the co-chair of our Reimbursement Working Group, Rob Dumanois, from Thermo Fisher Scientific. Thank you Rob for leading the working group session at the Q3 meeting and for sharing your thoughts! #Reimbursement #liquidbiopsy #accessibility #inpersoncollaboration

With #ESMO24 as the backdrop, our Global Regulatory Working Group hosted a special dinner in Barcelona, Spain, last Friday. The evening focused on BLOODPAC’s strategic initiatives and explored potential collaborations to address barriers to #liquidbiopsy #accessibility in Europe. In partnership with local European experts, we plan to develop a program to tackle #regulatorychallenges, drive #marketadoption, and improve #patientaccess. A big thank you to everyone who attended the event! And a special shoutout to Xeixa for the delicious food and for being such wonderful hosts. If you're ever in Barcelona, it’s a must-visit restaurant!

Take a peek at our Q3 in-person meeting! 📽 A big thank you to our amazing hosts, Personalis, Inc. Inc., for making this gathering possible. And a special shoutout to our dedicated members—your passion and commitment to advancing the #liquidbiopsy field are what keep us moving forward. It was great to see our working groups come together and dive into two jam-packed days of productive sessions. They showcased impressive progress on #globalregulatory and #reimbursement pathways, #analyticalvalidation protocols, consensus in terminology, external study collaborations, and the growing impact of our data commons. Big updates are on the horizon—stay tuned!

Thank you, Personalis, Inc., for being such incredible hosts of BLOODPAC’s Q3 in-person meeting! 🙌 We are deeply grateful for your hospitality and for providing a space where our members could engage in productive discussions, collaborate meaningfully, and advance the liquid biopsy field. It was a pleasure to see our members strengthen relationships, make meaningful progress toward our mission while also having fun.